The authors would like to include the following disclosure of potential conflicts of interest. The authors would like to apologise for any inconvenience caused.
Jacqueline Aredo:
Advisory/consulting role: AstraZeneca, Johnson & Johnson, Bristol Meyers Squibb
Honorarium: Binaytara Foundation, Kaplan, IDEOlogy Health
Chloe Su:
Advisory/consulting role: Revamp Medical
Employment, travel: Revolution medicines
Equity and stocks: 10x Genomics, Teladoc Health, Moderna, Revolution medicines
Nathaniel Myall:
Advisory/consulting role: Nuvalent Inc.
Funding grants: Genentech, BlossomHill Therapeutics
Heather Wakelee:
Advisory/consulting role: IoBiotech, BeOne, GSK, Regeneron
Equity or stocks (stock option only) and advisory/consulting role: OncoC4
Funding grants: Henlius, Xcovery, Glead
Funding grants and advisory/consulting role: AstraZeneca, Gen entech/Roche, Merck, Pfizer (SeaGen)